Suppr超能文献

焦虑障碍患者评估和量化健康状况的 EQ-5D 的有效性和反应度。

Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders.

机构信息

Department of Medical Sociology and Health Economics, University Medical Center Hamburg-Eppendorf, Martinistr, 52, 20246 Hamburg, Germany.

出版信息

Health Qual Life Outcomes. 2010 May 5;8:47. doi: 10.1186/1477-7525-8-47.

Abstract

BACKGROUND

The EQ-5D is a generic questionnaire which generates a health profile as well as index scores for health-related quality of life that may be used in cost-utility analysis.

AIMS OF THE STUDY

To examine validity and responsiveness of the EQ-5D in patients with anxiety disorders.

METHODS

389 patients with anxiety disorders completed the EQ-5D at baseline and 6-month follow-up. Subjective measures of quality of life (WHOQOL-BREF) and psychopathology (BAI, BDI-II, BSQ, ACQ, MI) were used for comparison. Validity was analyzed by assessing associations between EQ-5D scores and related other scores. Responsiveness was analyzed by calculating effect sizes of differences in scores between baseline and follow-up for 3 groups indicating more, constant or less anxiety. Meaningful difference scores for shifting to less or more anxiety were derived by means of regression analysis.

RESULTS

88.4% of respondents reported problems in at least one of the EQ-5D dimension at baseline; the mean EQ VAS score was 63.8. The EQ-5D dimension most consistently associated with the measures used for comparison was 'anxiety/depression'. EQ VAS and EQ-5D index scores were highly correlated (|r|>0.5) with scores of the WHOQOL-BREF dimensions 'physical', 'mental' and 'overall' as well as BAI and BDI-II. The EQ-5D index tended to be the most responsive score. Standardized meaningful difference scores were not significantly different between EQ VAS, EQ-5D index and measures used for comparison.

CONCLUSIONS

The EQ-5D seems to be reasonably valid and moderately responsive in patients with anxiety disorders. The EQ-5D index may be suitable for calculating QALYs in economic evaluation of health care interventions for patients with anxiety disorders.

TRIAL REGISTRATION

Current Controlled Trials ISRCTN15716049.

摘要

背景

EQ-5D 是一种通用问卷,可生成健康状况概况和健康相关生活质量指数评分,可用于成本效用分析。

研究目的

检验焦虑障碍患者 EQ-5D 的有效性和反应度。

方法

389 例焦虑障碍患者在基线和 6 个月随访时完成 EQ-5D。使用主观生活质量量表(WHOQOL-BREF)和精神病理学量表(BAI、BDI-II、BSQ、ACQ、MI)进行比较。通过评估 EQ-5D 评分与相关评分之间的关联来分析有效性。通过计算 3 组(焦虑程度增加、不变、减少)评分在基线和随访之间的差异的效应量来分析反应度,3 组分别代表焦虑程度增加、不变和减少。通过回归分析得出向焦虑程度减少或增加转移的有意义的差异评分。

结果

88.4%的受访者在基线时报告至少有一个 EQ-5D 维度存在问题;EQ VAS 平均得分为 63.8。与用于比较的量表最一致相关的 EQ-5D 维度是“焦虑/抑郁”。EQ VAS 和 EQ-5D 指数评分与 WHOQOL-BREF 维度“身体”、“心理”和“总体”以及 BAI 和 BDI-II 的评分高度相关(|r|>0.5)。EQ-5D 指数评分具有中等反应度。EQ VAS、EQ-5D 指数评分和用于比较的量表的标准化有意义差异评分无显著差异。

结论

EQ-5D 在焦虑障碍患者中具有合理的有效性和中等的反应度。EQ-5D 指数可用于计算焦虑障碍患者医疗保健干预的成本效用分析中的 QALY。

试验注册

当前对照试验 ISRCTN80331024。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6427/2873595/938838cbe4ad/1477-7525-8-47-1.jpg

相似文献

2
Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders.
Eur Psychiatry. 2007 Apr;22(3):177-87. doi: 10.1016/j.eurpsy.2006.08.004. Epub 2006 Dec 4.
3
Responsiveness to change in health status of the EQ-5D in patients treated for depression and anxiety.
Health Qual Life Outcomes. 2023 Apr 15;21(1):35. doi: 10.1186/s12955-023-02116-y.
4
The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning.
Drug Alcohol Depend. 2007 Jan 12;86(2-3):253-64. doi: 10.1016/j.drugalcdep.2006.07.001. Epub 2006 Aug 22.
9
Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany.
Inflamm Bowel Dis. 2010 Jan;16(1):42-51. doi: 10.1002/ibd.20989.

引用本文的文献

1
Quality of life and financial implications of depression in India.
Indian J Psychiatry. 2025 Jul;67(7):675-684. doi: 10.4103/indianjpsychiatry_170_25. Epub 2025 Jul 15.
3
Predicting Long-Term Health-Related Quality of Life in Individuals With Prior SARS-CoV-2 Infection: A 12-Month Prospective Study.
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251342650. doi: 10.1177/21501319251342650. Epub 2025 May 28.

本文引用的文献

1
Responsiveness of the EQ-5D to HADS-identified anxiety and depression.
J Eval Clin Pract. 2009 Oct;15(5):820-5. doi: 10.1111/j.1365-2753.2008.01102.x.
2
Cost-effectiveness of a primary care model for anxiety disorders.
Br J Psychiatry. 2009 Oct;195(4):308-17. doi: 10.1192/bjp.bp.108.058032.
3
Validating the EQ-5D with time trade off for the German population.
Eur J Health Econ. 2005 Jun;6(2):124-30. doi: 10.1007/s10198-004-0264-z.
6
Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: a systematic review.
J Affect Disord. 2009 Apr;114(1-3):14-31. doi: 10.1016/j.jad.2008.07.014. Epub 2008 Sep 3.
7
Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
J Psychiatr Res. 2008 Oct;42(12):1042-9. doi: 10.1016/j.jpsychires.2007.11.006. Epub 2008 Jan 24.
9
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.
Ann Intern Med. 2007 Mar 6;146(5):317-25. doi: 10.7326/0003-4819-146-5-200703060-00004.
10
The usefulness of the EQ-5D in differentiating among persons with major depressive episode and anxiety.
Qual Life Res. 2007 Jun;16(5):749-54. doi: 10.1007/s11136-006-9159-z. Epub 2007 Feb 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验